Literature DB >> 19138031

Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.

Sydney M Evans1, Kevin W Jenkins, W Timothy Jenkins, Thomas Dilling, Kevin D Judy, Amy Schrlau, Alexander Judkins, Stephen M Hahn, Cameron J Koch.   

Abstract

Tissue hypoxia results from the interaction of cellular respiration, vascular oxygen carrying capacity, and vessel distribution. We studied the relationship between tumor vasculature and regions of low pO(2) using quantitative analysis of binding of the 2-nitroimidazole EF5 given to patients intravenously (21 mg/kg) approximately 24 h preceding surgery. We describe new computer algorithms for determining EF5 binding as a function of radial distance from individual blood vessels and converting this value to tissue pO(2). Tissues from six human brain tumors were assessed. In a hemangiopericytoma, a WHO Grade 2 and WHO Grade 3 glial brain tumor, all tissue pO(2) values calculated by EF5 binding were >20 mmHg (described as "physiologically oxygenated"). In these three tumors, EF5 binding gradients (measured as a function of distance from each observed vessel) were low, with small positive and negative values averaging close to zero. Much lower tissue oxygen levels were found, including near some vessels, in glioblastomas. Gradients of EF5 binding away from vessels were larger in glioblastomas than in the low-grade tumors, but positive and negative values again averaged to near zero. Based on these preliminary data, we hypothesize a new paradigm for tumor blood flow in human brain tumors whereby in-flowing and out-flowing blood patterns may have contrasting effects on average tissue EF5 (and by inference, oxygen) gradients. Our studies also imply that neither distance to the nearest blood vessel nor distance from each observed blood vessel provide reliable estimates of tissue pO(2).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19138031      PMCID: PMC2629387          DOI: 10.1667/RR1207.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  66 in total

1.  The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue.

Authors:  A Krogh
Journal:  J Physiol       Date:  1919-05-20       Impact factor: 5.182

2.  Importance of antibody concentration in the assessment of cellular hypoxia by flow cytometry: EF5 and pimonidazole.

Authors:  Cameron J Koch
Journal:  Radiat Res       Date:  2008-06       Impact factor: 2.841

3.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

4.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

5.  Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.

Authors:  Laurence Goethals; Annelies Debucquoy; Christiaan Perneel; Karel Geboes; Nadine Ectors; Harlinde De Schutter; Freddy Penninckx; William H McBride; Adrian C Begg; Karin M Haustermans
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-05-01       Impact factor: 7.038

6.  Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix.

Authors:  M Höckel; C Knoop; K Schlenger; B Vorndran; E Baussmann; M Mitze; P G Knapstein; P Vaupel
Journal:  Radiother Oncol       Date:  1993-01       Impact factor: 6.280

7.  Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas.

Authors:  Marianne Nordsmark; Juliette Loncaster; Christina Aquino-Parsons; Shu Chuan Chou; Morten Ladekarl; Hanne Havsteen; Jacob C Lindegaard; Susan E Davidson; Mahesh Varia; Catharine West; Robin Hunter; Jens Overgaard; James A Raleigh
Journal:  Radiother Oncol       Date:  2003-04       Impact factor: 6.280

8.  2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors.

Authors:  S M Evans; W T Jenkins; B Joiner; E M Lord; C J Koch
Journal:  Cancer Res       Date:  1996-01-15       Impact factor: 12.701

9.  A marker for hypoxic cells in tumours with potential clinical applicability.

Authors:  J D Chapman; A J Franko; J Sharplin
Journal:  Br J Cancer       Date:  1981-04       Impact factor: 7.640

10.  Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas.

Authors:  K I Wijffels; J H Kaanders; P F Rijken; J Bussink; F J van den Hoogen; H A Marres; P C de Wilde; J A Raleigh; A J van der Kogel
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

View more
  20 in total

1.  Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors.

Authors:  Cameron J Koch; W Timothy Jenkins; Kevin W Jenkins; Xiang Yang Yang; A Lee Shuman; Stephen Pickup; Caitlyn R Riehl; Ramesh Paudyal; Harish Poptani; Sydney M Evans
Journal:  Tumor Microenviron Ther       Date:  2013-01

2.  Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.

Authors:  Eli E Bar; Alex Lin; Vasiliki Mahairaki; William Matsui; Charles G Eberhart
Journal:  Am J Pathol       Date:  2010-07-29       Impact factor: 4.307

3.  The radiation response of cells from 9L gliosarcoma tumours is correlated with [F18]-EF5 uptake.

Authors:  Cameron J Koch; Anne L Shuman; Walter T Jenkins; Alexander V Kachur; Joel S Karp; Richard Freifelder; William R Dolbier; Sydney M Evans
Journal:  Int J Radiat Biol       Date:  2009-12       Impact factor: 2.694

4.  Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.

Authors:  Cameron J Koch; Joshua S Scheuermann; Chaitanya Divgi; Kevin D Judy; Alexander V Kachur; Richard Freifelder; Janet S Reddin; Joel Karp; James B Stubbs; Stephen M Hahn; Jason Driesbaugh; Deborah Smith; Susan Prendergast; Sydney M Evans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-29       Impact factor: 9.236

Review 5.  Hypoxia and fetal heart development.

Authors:  A J Patterson; L Zhang
Journal:  Curr Mol Med       Date:  2010-10       Impact factor: 2.222

Review 6.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

7.  Automated measurement of microcirculatory blood flow velocity in pulmonary metastases of rats.

Authors:  Gert Blueschke; Gabi Hanna; Andrew N Fontanella; Gregory M Palmer; Alina Boico; Hooney Min; Mark W Dewhirst; David C Irwin; Yulin Zhao; Thies Schroeder
Journal:  J Vis Exp       Date:  2014-11-30       Impact factor: 1.355

8.  Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).

Authors:  Ernst J Postema; Alexander J B McEwan; Terence A Riauka; Piyush Kumar; Dacia A Richmond; Douglas N Abrams; Leonard I Wiebe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-09       Impact factor: 9.236

9.  Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma.

Authors:  Arnulf Mayer; Fabienne Schneider; Peter Vaupel; Clemens Sommer; Heinz Schmidberger
Journal:  Int J Oncol       Date:  2012-07-16       Impact factor: 5.650

Review 10.  Usefulness of FMISO-PET for glioma analysis.

Authors:  Hiroyuki Kobayashi; Kenji Hirata; Shigeru Yamaguchi; Shunsuke Terasaka; Tohru Shiga; Kiyohiro Houkin
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-10-29       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.